Perosphere
Perosphere employs rational drug design to invent proprietary new small molecules for targeted therapeutic indications.
Launch date
Employees
Market cap
-
Enterprise valuation
$25—37m (Dealroom.co estimates Feb 2016.)
Mount Kisco New York (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $1.0m | Series A | |
| N/A | $1.0m | Seed | |
$1.5m | Debt | ||
| N/A | $2.1m | Series B | |
| N/A | $6.2m | Early VC | |
* | N/A | Acquisition | |
| Total Funding | $10.3m | ||
Related Content
Recent News about Perosphere
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.